Is CIPLA LAMIVUDINE ORAL SOLUTION registered in South Africa?

CIPLA LAMIVUDINE ORAL SOLUTION is recorded with registration status “Canceled” in South Africa, registration number 37/20.2.8/0615, based on SAHPRA data.

What is the active ingredient in CIPLA LAMIVUDINE ORAL SOLUTION?

CIPLA LAMIVUDINE ORAL SOLUTION contains None.

Canceled South Africa · SAHPRA

CIPLA LAMIVUDINE ORAL SOLUTION

None

37/20.2.8/0615

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.

37/20.2.8/0615

Registration date

2004/07/23

Expiry date

Status

Canceled

Active ingredient

None

Dosage form

Strength

Pack size

Therapeutic class

Manufacturer / MAH

Applicant / LTR

Cipla Medpro (Pty) Ltd

Country of origin

Source: South African Health Products Regulatory Authority · fetched 2026-04-15 21:15:46 · updated 2026-09-16 04:00:24

Disclaimer: This information is sourced from South African Health Products Regulatory Authority (South Africa). Always consult a qualified healthcare professional before using any medication.